XORTX Therapeutics (XRTX) Non Operating Interest Expenses (2020 - 2026)
XORTX Therapeutics (XRTX) recorded Non Operating Interest Expenses of $2,686 in the quarter ended Jun 30, 2026, down 78.2% from $12,326 a year earlier but up 64.3% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
On a TTM basis, XORTX Therapeutics' Non Operating Interest Expenses came in at $15,444 as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at $41,870, down 65.7% from the prior year.
- Across earlier years, Non Operating Interest Expenses came in at $121,908 in the year ended Dec 31, 2024 (-51.9%), $253,543 in the year ended Dec 31, 2023 (+144.8%), $103,589 in the year ended Dec 31, 2022 and -$4,451 in the year ended Dec 31, 2021.
- Quarterly Non Operating Interest Expenses has ranged from -$54,577 in the quarter ended Jun 30, 2023 to $63,614 in the quarter ended Sep 30, 2023 over the past five years.
- Per Business Quant, the preceding three quarters came in at $1,635 (quarter ended Mar 31, 2026), $3,922 (quarter ended Dec 31, 2025) and $7,201 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | XORTX Therapeutics | 1.60 Mn | -1.70 Mn | - | 2,686.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,686.00 |
| Mar 31, 2026 | 1,635.00 |
| Dec 31, 2025 | 3,922.00 |
| Sep 30, 2025 | 7,201.00 |
| Jun 30, 2025 | 12,326.00 |
| Mar 31, 2025 | 18,421.00 |
| Dec 31, 2024 | -25,331.00 |
| Sep 30, 2024 | -29,023.00 |
| Jun 30, 2024 | -35,952.00 |
| Mar 31, 2024 | 31,602.00 |
| Dec 31, 2023 | 49,815.00 |
| Sep 30, 2023 | 63,614.00 |
| Jun 30, 2023 | -54,577.30 |
| Mar 31, 2023 | -49,413.20 |
| Dec 31, 2022 | -39,572.74 |
| Sep 30, 2022 | -27,188.82 |
| Jun 30, 2022 | -9,226.98 |
| Mar 31, 2022 | -3,354.00 |
| Dec 31, 2021 | 1,669.00 |
| Sep 30, 2021 | 871.47 |
API Access
XORTX Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();